Literature DB >> 31464023

A preliminary study on the differential expression of long noncoding RNAs and messenger RNAs in obese and control mice.

Ping Li1, Xiaoyu Chen1, Xuelian Chang1, Tiantian Tang1, Kemin Qi1.   

Abstract

Obesity has become one of the public health problems that threatens children's health, but its specific etiology and pathogenesis are still unclear. Recently, many long noncoding RNAs (lncRNAs) have been shown to be involved in the occurrence of obesity. However, their roles are still poorly understood. Thus, the aim of this study was to discover the profiles of the lncRNAs and messenger RNAs (mRNAs) altered in obesity. Epididymal fat samples were collected from mice fed with control and high-fat diets (HFD) for 16 weeks to investigate the differentially expressed lncRNAs and mRNAs by lncRNA microarray, after which seven lncRNAs and nine mRNAs were validated using reverse-transcription polymerase chain reaction (RT-PCR). Bioinformatics analysis and predictions were used to determine the potential biofunctions of these differentially expressed lncRNAs. Then a coexpression network was constructed to determine the transcriptional regulatory relationship of the differentially expressed lncRNAs and mRNAs between the control and HFD groups. The body weight of the HFD group was much higher than that of the control group, as a result of the increased energy intake. In total, 8421 differentially expressed lncRNAs and 6840 mRNAs were profiled using the lncRNAs microarray. Bioinformatics predictions and the coexpression network all indicated that the occurrence of obesity was attributed to those differentially expressed lncRNAs and mRNAs associated with energy metabolism, cell differentiation, and oxidative phosphorylation. The expression levels of Cyp2e1, Atp5b, Hibch, Cnbp, Frmd6, Ptchd3, ENSMUST00000155948, AK140152, ENSMUST00000135194, and ENSMUST00000180861 were significantly different between the control and HFD groups. All these Results suggested that obesity was partially attributed to those lncRNAs associated with energy metabolism, cell differentiation, and oxidative phosphorylation.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  epididymal fat; bioinformatics; long noncoding RNA; messenger RNA; obesity

Mesh:

Substances:

Year:  2019        PMID: 31464023     DOI: 10.1002/jcb.29348

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Relationship between the Levels of lncRNA H19 in Plasma and Different Adipose Tissue Depots with Patients' Response to Bariatric Surgery.

Authors:  Marina S Artemyeva; Ludmila B Vasileva; Yi Ma; Kirill A Kondratov; Anton V Fedorov; Anna A Kostareva; Sofia E Lapshina; Anna D Anopova; Nikolai P Likhonosov; Alexander E Neymark; Alina Yu Babenko; Evgeny V Shlyakhto
Journal:  Life (Basel)       Date:  2022-04-25

2.  The Long Noncoding RNA Blnc1 Protects Against Diet-Induced Obesity by Promoting Mitochondrial Function in White Fat.

Authors:  Shengjie Tang; Weifen Zhu; Fenping Zheng; Weiwei Gui; Wenjing Zhang; Xihua Lin; Hong Li
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-17       Impact factor: 3.168

3.  Proteomic characterization and comparison of ram (Ovis aries) and buck (Capra hircus) spermatozoa proteome using a data independent acquisition mass spectometry (DIA-MS) approach.

Authors:  Wen Zhu; Xiao Cheng; Chunhuan Ren; Jiahong Chen; Yan Zhang; Yale Chen; Xiaojiao Jia; Shijia Wang; Zhipeng Sun; Renzheng Zhang; Zijun Zhang
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

4.  miR-379 mediates insulin resistance and obesity through impaired angiogenesis and adipogenesis regulated by ER stress.

Authors:  Maryam Abdollahi; Mitsuo Kato; Linda Lanting; Ragadeepthi Tunduguru; Mei Wang; Yangmeng Wang; Patrick T Fueger; Qiong Wang; Wendong Huang; Rama Natarajan
Journal:  Mol Ther Nucleic Acids       Date:  2022-09-19       Impact factor: 10.183

Review 5.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.